Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant - PA: Nutrition, Metabolism and Diabetes

University of British Columbia

$100,000.00

SOX4 regulation of human islet cell genesis and growth

EF 2022-23

Résumé
Diabetes is a chronic, incurable disease with devastating complications. The hallmark symptom of diabetes is sustained elevation in blood glucose levels, which results from reduced function of the insulin-secreting beta cell within the pancreas. Population studies and DNA sequencing have identified genetic variation that increases the risk of developing diabetes; however, how much of this variation leads to disease is unknown. Here we propose using cutting-edge technologies to generate human disease models and that carry the genetic differences that predispose to Type 2 diabetes. We will then study how these genetic changes lead to reductions of insulin secretion and likely cause diabetes. We expect these studies to will allow a greater understanding of how genetic variation in some people leads to diabetes and uncover new, human-specific beta cell pathways that could be targeted for development of therapeutics for Canadians with diabetes.
Programme
Project Grant - PA: Nutrition, Metabolism and Diabetes
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
484106
Name
Lynn Francis C
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
SOX4 regulation of human islet cell genesis and growth
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Nutrition, Metabolism and Diabetes
Keyworddelim
Development; Diabetes; Disease Risk; Stem Cells; Transcription
Abstract
Diabetes is a chronic, incurable disease with devastating complications. The hallmark symptom of diabetes is sustained elevation in blood glucose levels, which results from reduced function of the insulin-secreting beta cell within the pancreas. Population studies and DNA sequencing have identified genetic variation that increases the risk of developing diabetes; however, how much of this variation leads to disease is unknown. Here we propose using cutting-edge technologies to generate human disease models and that carry the genetic differences that predispose to Type 2 diabetes. We will then study how these genetic changes lead to reductions of insulin secretion and likely cause diabetes. We expect these studies to will allow a greater understanding of how genetic variation in some people leads to diabetes and uncover new, human-specific beta cell pathways that could be targeted for development of therapeutics for Canadians with diabetes.
Competitiondate
202303
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lynn, Francis C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~